Analysis: Get Ready For The Vaccine — They’re Never Simple
Trials are an immense undertaking involving tens of thousands of participants. They’re likely to start this summer — but don’t expect quick results. And what’s a successful result, anyway?
The independent source for health policy research, polling, and news.
Trials are an immense undertaking involving tens of thousands of participants. They’re likely to start this summer — but don’t expect quick results. And what’s a successful result, anyway?
Just about anyone who wants a coronavirus test in the state of Tennessee can get one. How? The state got buy-in and lots of participation from private labs by assuring them it will pay them.
Maine investigators find one patient’s saga with O’NA HealthCare offers a cautionary tale for anyone looking for cut-rate coverage online.
An affluent suburb looked to Iceland’s and South Korea’s widespread testing in an effort to slow the spread of the coronavirus. The method is pricey, but leaders are convinced it is worthwhile.
Accident deaths are typically the biggest source of donor organs nationwide. But when the coronavirus forced Californians indoors, accidents declined.
Children’s hospitals were generally in good shape before COVID-19, but now their revenues are plunging as beds they reserved to assist in the pandemic effort remain empty.
Early in the outbreak, some coroners and medical examiners didn’t have enough tests to use for people who died unexpectedly at home to see whether the coronavirus was a factor. Now, as testing gradually becomes widely available, more such mysteries could be solved.
Many travel insurance plans offer health care coverage, but they could limit how much the insurer will pay or exclude coverage for health crises like the coronavirus pandemic. That may leave foreign travelers — unfamiliar with the way the American health system works ― on the hook for major expenses.
Congress authorized $100 billion for health care providers to help reimburse them for losses linked to the coronavirus pandemic. But the majority of that funding so far has gone to hospitals, doctors and other facilities that serve Medicare patients. Providers primarily serving low-income Medicaid populations and children have been largely left out.
A podcast listener who works in the health insurance industry says that when you’re trying to untangle a problem with your health insurance company ask the representative on the phone to slow down. And if need be, don’t hesitate to ask to speak with a supervisor.
After a police shooting in Indianapolis, activists held a protest — but, recognizing the dangers of the coronavirus in a crowd, many worked to make sure demonstrators took proper precautions.
Vaccines and antivirals have long been an afterthought but Johnson & Johnson and other firms are widely publicizing how they might stop COVID 19.
KHN’s Julie Rovner joined other journalists on Friday’s ‘On Point’ broadcast to talk about health news, including states relaxing their stay-at-home orders and Capitol Hill hearings featuring testimony before Congress by Drs. Anthony Fauci and Rick Bright.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
There’s an actual paper trail.
Under pressure from organizations representing doctors, nurses, hospitals and other care providers, a handful of states are offering them protections from civil lawsuits over medical treatment.
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
Before the coronavirus hit, California was looking at a budget surplus of more than $5 billion and lawmakers were debating how to increase the size of government health programs. Now, the state faces a deficit, program cuts, high unemployment — and no significant investment in public health funding at a time when the state needs it the most.
Following a KCUR report, Kansas officials said the state’s public reporting of pandemic trends will count all tests that come back positive for the new coronavirus, even when the patient has no symptoms.
House Democrats unveiled legislation that would effectively double what the federal government has spent on relief for the COVID-19 pandemic, but Republicans say they want to wait before even talking about another bill. Meanwhile, a key Republican senator called the GOP court case challenging the Affordable Care Act “flimsy.” Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss this and more.
Subscribe to KFF Health News' free Morning Briefing.
Noticias en español
© 2026 KFF